Movement Disorders · 2012 · 129 citations · 13 references
MedicineNeurologyRadiologyDiagnostic ImagingNeurodegenerationUltrasonographyBrain ImagingNeurodegenerative Disease ImagingNeurodegenerative DiseasesNeurodegenerative DisordersParkinson DiseaseParkinsonian DisordersBiomarkers Of Parkinsonian DisordersNeurodegeneration Risk MarkersNeuroimaging In Parkinson's DiseaseParkinson Disease BiomarkersParkinson Disease ImagingParkinson Disease PathologyRisk Marker AnalysisRisk Marker Identification
BACKGROUND: SN hyperechogenicity (SN+), determined by transcranial sonography, has been proposed as a risk factor for Parkinson's disease (PD). Recently, we reported a 17.4-fold increased risk for PD in individuals with SN+ older than 50 years within 3 years. METHODS: This is the second follow-up of a prospective, longitudinal, three-center observational study after 5 years. Of the initial 1,847 at baseline PD-free participants 50 years or older, 1,271 underwent the 5-year reassessment. RESULTS: Within 5 years, 21 individuals developed incident PD. Participants with SN+ at baseline had a more than 20.6 times increased risk to develop PD in this time span than those without this echo feature. CONCLUSION: We thus confirm our finding of the 3-year follow-up examination in a longer observation time and higher number of individuals with incident PD and suggest SN+ as an important risk marker for PD.
13
Association of olfactory dysfunction with risk for future Parkinson's disease
G. Webster Ross, Helen Petrovitch, Robert D. Abbott et al. · Annals of Neurology · 2007 · 744 citations
Medicine, Neurology, Neuroscience +16
Álex Iranzo, Francisco Lomeña, Heike Stockner et al. · The Lancet Neurology · 2010 · 387 citations
Medicine, Neurology, Neuroscience +14
Five‐year follow‐up study of hyperechogenicity of the substantia nigra in Parkinson's disease
Daniela Berg, B. Merz, Karlheinz Reiners et al. · Movement Disorders · 2004 · 242 citations
Medicine, Neuroscience, Radiology +13